← All Pure Bioscience, INC filings

Pure Bioscience, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OQB
PURE
Pure Bioscience, INC
10-K: PURE Bioscience Reports FY25 Loss, Raises Capital
PURE Bioscience, Inc. reported a net loss of $2.4 million for fiscal year 2025, despite a slight increase in net product sales, and continues to rely on convertible debt financing from related parties.
OQB
PURE
Pure Bioscience, INC
10-K: PURE Bioscience Reports Fiscal Year 2024 Results, Highlights Ongoing Concerns
PURE Bioscience's annual report reveals a net loss of $3.4 million for fiscal year 2024 and raises concerns about the company's ability to continue as a going concern.